On January 9, 2017, the 16th participant was enrolled at the Charleston, South Carolina study site of our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic setting by healthy volunteers. On December 14, 2016, the fifth participant was enrolled at the Boulder, Colorado study site. Michael Mithoefer, M.D., and Ann Mithoefer, B.S.N., are serving as Principal Investigators at the Charleston site, and Marcela Ot’alora, M.A., L.P.C., is serving as Principal Investigator of the Boulder site. Enrollment in this study is limited by invitation only to therapists in training to work on MAPS-sponsored clinical trials of MDMA-assisted psychotherapy for PTSD. This study has currently enrolled 21 out of 100 participants across the study sites in Colorado and South Carolina. Learn more…
